Differential diagnosis of central nervous system manifestations of the Antiphospholipid Antibody Syndrome

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Anti-phospholipid antibodies (aPL) have been associated with a variety of neurologic manifestations. The evidence for an association between aPL and most of these is weak because (1) no association actually exists, (2) the manifestation is rare or (3) sufficiently powered studies have not been performed. The only neurologic manifestation that is considered to have sufficient evidence to justify it being a part of the criteria for the diagnosis of Anti-phospholipid Antibody Syndrome (APS) is cerebral ischemia. In this mini-review, most of the neurologic syndromes with an actual or suspected association with aPL are considered. The role of aPL in the differential diagnosis of these syndromes is considered as well. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)133-138
Number of pages6
JournalJournal of Autoimmunity
Volume15
Issue number2
DOIs
StatePublished - 2000

Keywords

  • Antiphospholipid antibodies
  • Cerebral ischemia
  • Cognitive dysfunction
  • Dementia
  • Multiple sclerosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Differential diagnosis of central nervous system manifestations of the Antiphospholipid Antibody Syndrome'. Together they form a unique fingerprint.

Cite this